Cancer patients in the UK will test drug to reduce weight loss and fatigue caused by the disease

The drug bermekimab has been hailed as 'radical' by experts. Patients with lung, pancreatic and ovarian cancer will be the first to be recruited by researchers at the University of Edinburgh.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news